Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling

Ovarian Cancer (OC) is a highly lethal gynecological cancer which often progresses through acquired resistance against the administered therapy. Cisplatin is a common therapeutic for the treatment of OC patients and therefore it is critical to understand the mechanisms of resistance against this dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Wen-Xi, Sun, Ge, Shangguan, Meng-Yuan, Gui, Zhi, Bao, Yang, Li, Yu-Feng, Jia, Zan-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478977/
https://www.ncbi.nlm.nih.gov/pubmed/32901049
http://dx.doi.org/10.1038/s41598-020-71153-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478977/
https://www.ncbi.nlm.nih.gov/pubmed/32901049
http://dx.doi.org/10.1038/s41598-020-71153-0

Ejemplares similares